AbbVieEyetoEye的动态

With J&Js recent acquisition of Shockwave Medical, I think it's fair to say M&A is front of mind for everyone in the industry. Definitely one to block out in your calendar!

A great session highlighting how Med Tech is not just about the “Tech”. To better understand and fix the whole problem / pathway you need to know the views and opinions of all involved, especially our patients. Well done Gianluca Casali, and the whole panel. Johnson & Johnson MedTech

Koispace Fam, As we prepare for our February 27th virtual meetup, we wanted to share an important update—this will be the final Coffee Chat gathering. When we kicked off our very first chat in February 2022, it was intended to be a short pilot—just a few sessions. But the community and conversations blossomed, leading us to continue the biweekly meetings for nearly two years! Members from around the world have come together during this time to exchange stories, knowledge, laughter, and support. While we've cherished the Chats, we also recognize opportunities to make something even better. In particular, we want to focus on two areas of improvement: ?Creating a more inclusive format accessible from anywhere, across different time zones ?Providing more meaningful opportunities for professional development Though this chapter must come to a close, our journey continues. The Koispace patient network is evolving to create more meaningful opportunities, like an exciting new service facilitating virtual introductions between patient experts and pharmaceutical/health tech companies. Of course, the group camaraderie does not end here. We invite you to stay engaged through other platforms like KoiSpace Plus and remain a vital part of this community. Tuesday may be our last Coffee Chat, but it marks a bold new beginning rather than an end. Please join us at 5 pm CEST |?8 am PDT | 11 am EDT on February 27th as we celebrate this transition together. As we chart the course ahead, we welcome your thoughts and feedback. With gratitude,

This is an important case study - or more pertinently it shines a light on some important principles that I will spend a little time discussing them There are those that might scoff and ask why a multinational company would engage a small #consultancy at all - let alone for the reasons we engaged as per the case study. This is a fairly superficial and crass take (forgive me for going there- discussion point below) Instead I suggest this demonstrates a position of confidence and growth mindset which is a credit to Jess Baldry and Roberto Anello. A well-oiled slick machine like AGFA HealthCare strives for continued excellence and incremental improvement. To benchmark themselves we explored my "testing" their public facing team in the same way a Penetration Tester assesses the Cybersecurity systems in a server room. We at SMR Health & Tech were the proxy NHS Trust wishing to procure services. Using our combined #procurement and #EnterpriseImaging experience we curated the landscape and needs to benchmark. It was a fascinating project in the aftermath exploring what was said vs what was heard and how to bring the 2 positions even closer together Equally the positive moments where even with an "Eagle" mindset we were impressed by the manners aspects were articulated These engagements rely on mutual trust and not looking for problems for problems sake but a meaningful yet comprehensive exploration of multiple factors. It was particularly humbling for me because it was predicated on the basis "We consider you a #KOL (Key Opinion Leader) Rizwan thus your opinions are important to us" All too often people bandy around such terms without really leaning into the value of them or having the strength of conviction to own the engagements How many of you, for example, in the consulting space have worked "behind the curtains" - providing support but the SME or Multinational are reluctant to acknowledge having outside input? I've done my fair share of these and they absolutely play an important role. Where the lines become blurred is when you're engaged to provide support but only to inform the "public face" in private We want your expertise but don't want you to have a seat at the table. Central Public sector organisations are notorious for this and for portfolio colleagues in their early years it can be particularly demoralising as that's when you're REALLY striving for validation (happy to discuss more about this offline!) I would politely suggest "Be more AGFA HealthCare " Be confident in engaging domain experts for review, reflection, innovation fresh eyes support and indeed validate yourselves by having KOLs in your #advisory boards ?? Personally I love this sort of work and engaging with colleagues who respect and trust you bring its own unique sense of purpose and joy.

It will be exiting to follow the work of Martin Jakobsson and his team at TüV SüD, with Their newly established role as the first Danish MDR Notified Body is a significant milestone for Denmark’s life-science ecosystem.. The absence of a notified body in Denmark has been a major roadblock, hindering the flourishing of our dynamic medtech scene and overall value creation. Start-ups and small to medium enterprises (SMEs) have felt the impact. Historically, this situation has made Denmark and the EU a less attractive market for life science, prompting companies to explore other countries and geographies. At Contura International A/S , we’ve witnessed this firsthand. Life science contributes to over 20% of Danish exports, but the rigide 2017 MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation) regulations in the EU have adversely affected growth rates and the number of patents filed according to Medicoindustrien. Calling for a more flexible and pragmatic approach to fortify our ecosystem With TüV SüD’s expertise and commitment, we’re optimistic that this new Notified Body will pave the way for innovative medical devices to swiftly enter the European market. Let’s strengthen our life-science landscape and foster more groundbreaking advancements.

Are you headed to HLTH next week? Let me know if you want to catch up! I would love to see you. We also have 2 spots left in our "Transforming Pharma R&D: Digital Solutions for Clinical Trial Design & Planning" workshop if this is an area of interest for you and want to be part of the conversation at HLTH. #HLTHVegas #ClinicalTrials #DigitalSolutions

"Thrilled to have been recognized for my knowledge in the Biomedical Engineers Meet quiz organized by Omron yesterday! ?? Grateful for the opportunity to connect with fellow professionals. Special thanks to Tetsuya Yamada OMRON Healthcare, Inc. Restech - Respiratory Technology and the entire Omron team for an engaging event! ?? #BiomedicalEngineers #OmronQuiz #ContinuousLearning"

Looking forward to this session, leapfrogging technology to bring transformational health impact for LMICs! Please join the discussions and reach out to me when you are around, #datasolidarity #healthequity PharmAccess